✦ LIBER ✦

Anti-IL-17A Autovaccination Prevents Clinical and Histological Manifestations of Experimental Autoimmune Encephalomyelitis

✍ Scribed by CATHERINE UYTTENHOVE; CAROLINE SOMMEREYNS; IVAN THÉATE; THOMAS MICHIELS; JACQUES VAN SNICK

Book ID: 111484257
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 129 KB
Volume: 1110
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1423.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of an anti-IL-17A auto-vacci

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis

✍ Catherine Uyttenhove; Jacques Van Snick 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract IL‐17 has been associated with multiple inflammatory disorders such as rheumatoid arthritis, asthma and multiple sclerosis. As these diseases require long‐term treatment we turned to an auto‐vaccine strategy for IL‐17 neutralization __in vivo__. Mouse IL‐17A was covalently linked to ova

Recombinant human β-galactoside binding

Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis

✍ Halina Offner; Bozena Celnik; Timothy S. Bringman; Denise Casentini-Borocz; Glen 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Antisense oligonucleotide blockade of al

Antisense oligonucleotide blockade of alpha 4 integrin prevents and reverses clinical symptoms in murine experimental autoimmune encephalomyelitis

✍ Kathleen J. Myers; Donna R. Witchell; Mark J. Graham; Seongjoon Koo; Madeline Bu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 859 KB

RETRACTED: Treatment with 7-O-tetradecan

RETRACTED: Treatment with 7-O-tetradecanoyl-genistein reduces IFN-γ and IL-17 levels in the brain and ameliorates clinical signs of experimental autoimmune encephalomyelitis

✍ Castro, Sandra B.R.; Rezende Junior, Celso O.; Alves, Caio C.S.; Dias, Alyria T. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 905 KB

Development of an anti-IL-12 p40 auto-va

Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection

✍ Catherine Uyttenhove; Berenice Arendse; Vincent Stroobant; Frank Brombacher; Jac 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Prevention of clinical and histological

Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1

✍ P. Fagone; K. Mangano; C. Quattrocchi; R. Motterlini; R. Di Marco; G. Magro; N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB